Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
SN7 SHORT NOTE 5M

Describe the normal mechanism of haemostasis. Add a note on the interpretation of the coagulation screening tests.

Pathology · 2nd Professional — Para-Clinical

Definition

Haemostasis is the physiological process that arrests bleeding from an injured vessel while keeping the blood fluid elsewhere.

The Sequence

  • 1. Vasoconstriction — transient reflex arteriolar spasm, augmented by endothelin → 2.
  • Primary haemostasis — platelets adhere to exposed collagen via von Willebrand factor and GpIb → Platelets are activated, change shape and release ADP and TXA2 → They aggregate through GpIIb/IIIa bridged by fibrinogen → the primary platelet plug → 3.
  • Secondary haemostasis — tissue factor activates the coagulation cascade → thrombin → fibrin → 4.
  • Stabilisation — polymerised fibrin and platelet aggregates form a permanent plug → 5.
  • Counter-regulation — tissue plasminogen activator and thrombomodulin limit the plug to the site of injury

The Coagulation Cascade

PathwayFactorsTestTriggered by
IntrinsicXII, XI, IX, VIIIAPTTContact with a negatively charged surface
ExtrinsicVIIPT / INRTissue factor — the physiologically important trigger
CommonX, V, II (prothrombin), I (fibrinogen), XIIIBoth PT and aPTT—
  • Vitamin K dependent factors — II, VII, IX and X, plus proteins C and S; mnemonic "1972"
  • Factor VII has the shortest half-life, which is why the PT/INR rises first in warfarin therapy, liver disease and vitamin K deficiency

CLINICAL PEARL

  • Platelet disorders and coagulation disorders bleed differently.
  • Platelet problems give immediate, superficial, mucocutaneous bleeding — petechiae, epistaxis, menorrhagia.
  • Coagulation problems give delayed, deep bleeding — haemarthrosis, muscle haematoma. The history alone usually indicates which system is at fault.

Interpreting the Screening Tests

PTAPTTPlateletsSuggests
ProlongedNormalNormalFactor VII deficiency; early warfarin, early liver disease, vitamin K deficiency
NormalProlongedNormalHaemophilia A (VIII) or B (IX); von Willebrand disease; heparin; antiphospholipid antibody
ProlongedProlongedNormalCommon pathway defect; established liver disease; vitamin K deficiency
ProlongedProlongedLowDIC; massive transfusion
NormalNormalLowThrombocytopenia — ITP, hypersplenism, marrow failure
NormalNormalNormalVascular disorder, or a platelet function defect — test bleeding time

Applied Aspects

  • Aspirin inhibits cyclo-oxygenase irreversibly, and since platelets have no nucleus its effect lasts their whole 7–10 day lifespan — hence stopping it a week before surgery
  • Clopidogrel blocks the ADP receptor; abciximab blocks GpIIb/IIIa — each targets a specific step above
  • Warfarin acts on vitamin K dependent factors and is monitored by INR; heparin acts through antithrombin III and is monitored by aPTT
  • Haemophilia A is X-linked, presenting with haemarthrosis and deep haematomas; von Willebrand disease is autosomal and mucocutaneous, and is the commonest inherited bleeding disorder
  • Vitamin K deficiency of the newborn is prevented by a single intramuscular dose at birth — one of the most cost-effective interventions in medicine

All questions in Haemodynamic Disorders

  1. Q1Define oedema. Describe its pathogenesis with the mechanisms involved. Differentiate transudate from exudate. ★
  2. Q2Define thrombosis. Describe Virchow triad and the morphology and fate of a thrombus. ★
  3. Q3Define embolism. Classify emboli and describe pulmonary, fat, air and amniotic fluid embolism. ★
  4. Q4Define shock. Classify it and describe its pathogenesis, stages and morphology. ★
  5. Q5Define disseminated intravascular coagulation. Describe its causes, pathogenesis, clinical features and laboratory findings. ★
  6. SN1Define infarction. Classify infarcts and describe the factors determining their effects. ★
  7. SN2Differentiate hyperaemia from congestion. Describe chronic venous congestion of the lung, liver and spleen. ★
  8. SN3Classify haemorrhage and describe its effects. ★
  9. SN4Describe fat embolism syndrome with its pathogenesis and clinical features. ★
  10. SN5Describe Virchow triad and its significance in thrombosis. ★
  11. SN6Describe pulmonary thromboembolism with its sources, consequences and diagnosis. ★
  12. SN7Describe the normal mechanism of haemostasis. Add a note on the interpretation of the coagulation screening tests.

Every Pathology chapter →

Scroll to Top